封面
市场调查报告书
商品编码
1547660

全球猪隻疫苗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Swine Vaccines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球猪隻疫苗市场需求预计将从2023年的21.2亿美元达到2032年近34.4亿美元的市场规模,2024-2032年研究期间复合年增长率为5.52%。

疫苗似乎可以诱发保护性免疫力。它由来自病毒、细菌毒素、细菌或寄生虫的抗原组成。将疫苗注射到猪体内以加速免疫反应,这将保护它们免受未来微生物的感染。猪疫苗可以是活疫苗,含有可在猪体内繁殖的活生物体,也可以是灭活疫苗,只包含不会在猪体内繁殖的灭活生物体。猪常用的疫苗有大肠桿菌腹泻、仔猪梭菌性痢疾、丹毒、细小病毒感染、胸膜肺炎放线桿菌引起的坏死性胸膜肺炎、猪肺炎支原体引起的地方性肺炎、产毒多杀性巴氏桿菌引起的萎缩性鼻炎等。

市场动态

猪肉消费的增加、养猪业的升级以及为保护猪免受流行病和其他威胁而采取的预防措施的不断加强,推动了全球对猪疫苗的需求。猪肉消费量的增加使得人们越来越需要使猪免受可能影响猪和威胁人类的所有可能的疾病的影响。感染、流行病和集约化生猪养殖的增加使得有效的疫苗接种在养猪业中势在必行。猪隻呼吸与繁殖症候群、猪流行性腹泻等疾病爆发,造成巨大损失。这些可以透过给怀孕母猪接种疫苗来控制。用于未满足疾病疫苗创新的研发支出也有所成长。然而,维护和处理储存条件的高额费用以及疫苗逆反应的可能性预计将阻碍全球猪隻疫苗的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球猪隻疫苗市场的每个细分市场进行了包容性评估。猪疫苗产业的成长和趋势为本研究提供了整体方法。

市场区隔

猪疫苗市场报告的这一部分提供了国家和区域层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 减毒活疫苗
  • 灭活疫苗
  • 亚单位疫苗
  • DNA疫苗
  • 重组疫苗

按类型

  • 猪流感
  • 古典猪瘟
  • 猪细小病毒
  • 猪圆环病毒2型
  • 孝敏
  • 胸膜肺炎放线桿菌
  • 蓝耳病
  • 手足口病
  • 伪狂犬病
  • PEDV
  • 其他的

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲猪疫苗市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。猪疫苗市场的主要参与者包括默克公司、Ceva、硕腾、勃林格殷格翰有限公司、Elanco、Indian。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:猪疫苗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球猪疫苗市场分析:按产品

  • 概述(按产品)
  • 历史和预测数据
  • 按产品分析
  • 减毒活疫苗
  • 灭活疫苗
  • 亚单位疫苗
  • DNA疫苗
  • 重组疫苗

第 6 章:全球猪疫苗市场分析:按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 猪流感
  • 古典猪瘟
  • 猪细小病毒
  • 猪圆环病毒2型
  • 孝敏
  • 胸膜肺炎放线桿菌
  • 蓝耳病
  • 手足口病
  • 伪狂犬病
  • PEDV
  • 其他的

第 7 章:全球猪疫苗市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:猪疫苗公司的竞争格局

  • 猪疫苗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Merck & Co. Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ceva
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Zoetis
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BoehringerIngelheim GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Elanco
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Indian
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11214069

The global demand for Swine Vaccines Market is presumed to reach the market size of nearly USD 3.44 Billion by 2032 from USD 2.12 Billion in 2023 with a CAGR of 5.52% under the study period 2024-2032.

Vaccines appear to induce protective immunity. It consists of antigens from viruses, bacterial toxins, bacteria, or parasites. Vaccines are injected into swine to accelerate an immune response, which will protect them against future infection with the organism. Swine vaccines can be live, containing living organisms that will multiply in the pig, or inactivated, consisting only killed organisms that will not multiply in the swine. Vaccines commonly used on pig includes E. coli diarrhea, clostridial dysentery of piglets, erysipelas, parvovirus infection, necrotic pleuropneumonia caused by Actinobacillus pleuropneumoniae, enzootic pneumonia caused by Mycoplasma hyopneumoniae, and atrophic rhinitis caused by toxigenic Pasteurella multocida.

MARKET DYNAMICS

An increase in pork consumption, escalating swine industry, and growing precautions taken to protect swine from epidemics and other threats drive the demand for swine vaccines worldwide. Rising pork consumption has given rise to a growing need to keep the swine free from every possible disease that could affect swine and threaten the human population. The growth of infection, epidemics, and intensive pig operations has made effective vaccination imperative in the swine industry. Outbreaks of diseases such as porcine respiratory and reproductive syndrome (PRRS) and porcine epidemic diarrhea have caused massive losses. These are controlled by vaccinating pregnant sows. There has also been growth in R&D expenditure for the innovation of unmet disease vaccines. However, high expenses of maintaining and handling storage conditions and the chance of a reverse reaction from vaccines are projected to impede the growth of global swine vaccines.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Swine Vaccines. The growth and trends of Swine Vaccines industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Swine Vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Type

  • Swine Influenza
  • Classical Swine Fever
  • Porcine Parvovirus
  • Porcine Circovirus Type 2
  • M.Hyo
  • Actinobacillus Pleuropneumonia
  • PRRS
  • Foot & Mouth Disease
  • Pseudorabies
  • PEDV
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Swine Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Swine Vaccines market include Merck & Co. Inc, Ceva, Zoetis, BoehringerIngelheim GmbH, Elanco, Indian. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. SWINE VACCINES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SWINE VACCINES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Attenuated Live Vaccines Historic and Forecast Sales By Regions
  • 5.5. Inactivated Vaccines Historic and Forecast Sales By Regions
  • 5.6. Subunit Vaccines Historic and Forecast Sales By Regions
  • 5.7. DNA Vaccines Historic and Forecast Sales By Regions
  • 5.8. Recombinant Vaccines Historic and Forecast Sales By Regions

6. GLOBAL SWINE VACCINES MARKET ANALYSIS BY TYPE

  • 6.1. Overview By Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Type
  • 6.4. Swine Influenza Historic and Forecast Sales By Regions
  • 6.5. Classical Swine Fever Historic and Forecast Sales By Regions
  • 6.6. Porcine Parvovirus Historic and Forecast Sales By Regions
  • 6.7. Porcine Circovirus Type 2 Historic and Forecast Sales By Regions
  • 6.8. M.Hyo Historic and Forecast Sales By Regions
  • 6.9. Actinobacillus Pleuropneumonia Historic and Forecast Sales By Regions
  • 6.10. PRRS Historic and Forecast Sales By Regions
  • 6.11. Foot & Mouth Disease Historic and Forecast Sales By Regions
  • 6.12. Pseudorabies Historic and Forecast Sales By Regions
  • 6.13. PEDV Historic and Forecast Sales By Regions
  • 6.14. Others Historic and Forecast Sales By Regions

7. GLOBAL SWINE VACCINES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE SWINE VACCINES COMPANIES

  • 8.1. Swine Vaccines Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF SWINE VACCINES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Merck & Co. Inc
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Ceva
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Zoetis
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. BoehringerIngelheim GmbH
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Elanco
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Indian
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Attenuated Live Vaccines Market Sales By Geography (USD MN)
  • Inactivated Vaccines Market Sales By Geography (USD MN)
  • Subunit Vaccines Market Sales By Geography (USD MN)
  • DNA Vaccines Market Sales By Geography (USD MN)
  • Recombinant Vaccines Market Sales By Geography (USD MN)
  • Analysis By Type (USD MN)
  • Swine Influenza Market Sales By Geography (USD MN)
  • Classical Swine Fever Market Sales By Geography (USD MN)
  • Porcine Parvovirus Market Sales By Geography (USD MN)
  • Porcine Circovirus Type 2 Market Sales By Geography (USD MN)
  • M.Hyo Market Sales By Geography (USD MN)
  • Actinobacillus Pleuropneumonia Market Sales By Geography (USD MN)
  • PRRS Market Sales By Geography (USD MN)
  • Foot & Mouth Disease Market Sales By Geography (USD MN)
  • Pseudorabies Market Sales By Geography (USD MN)
  • PEDV Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Swine Vaccines Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Swine Vaccines Report
  • Market Research Process
  • Market Research Methodology
  • Global Swine Vaccines Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Attenuated Live Vaccines Market Sales By Geography (USD MN)
  • Inactivated Vaccines Market Sales By Geography (USD MN)
  • Subunit Vaccines Market Sales By Geography (USD MN)
  • DNA Vaccines Market Sales By Geography (USD MN)
  • Recombinant Vaccines Market Sales By Geography (USD MN)
  • Global Market Analysis By Type (USD MN)
  • Swine Influenza Market Sales By Geography (USD MN)
  • Classical Swine Fever Market Sales By Geography (USD MN)
  • Porcine Parvovirus Market Sales By Geography (USD MN)
  • Porcine Circovirus Type 2 Market Sales By Geography (USD MN)
  • M.Hyo Market Sales By Geography (USD MN)
  • Actinobacillus Pleuropneumonia Market Sales By Geography (USD MN)
  • PRRS Market Sales By Geography (USD MN)
  • Foot & Mouth Disease Market Sales By Geography (USD MN)
  • Pseudorabies Market Sales By Geography (USD MN)
  • PEDV Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.